Latest News Release

Oncolytics Biotech Inc. Receives $5 Million in Proceeds From Warrants Issued on June 19, 2003

Oncolytics Biotech Inc. Appoints Dr. Matt Coffey as Chief Scientific Officer

Oncolytics Biotech Inc. Closes $10 Million Bought Deal Financing

Oncolytics Biotech Inc. Enters into a Bought Deal Financing for $10 Million

Oncolytics Biotech Inc. Announces 2004 Third Quarter Results

Oncolytics Biotech Inc. Announces Issuance of 13th U.S. Patent

Oncolytics Biotech Inc. to Present at the 6th Annual Mass Opps Investment Conference

Oncolytics Biotech Inc. Announces Issuance of 12th U.S. Patent


Year

Oncolytics Biotech® Announces Poster Presentation at the 2018 Gastrointestinal Cancers Symposium Sponsored by ASCO in Patients with Relapsed Metastatic Adenocarcinoma of the Pancreas Read More

Oncolytics Biotech® Receives Favorable Final Advice Letter from the European Medicines Agency for REOLYSIN® in Metastatic Breast Cancer Read More

View all news articles

Exploring REOLYSIN®’s Objective Response Rate in Females with Colorectal Cancer Read More

Exploring REOLYSIN<sup>®</sup>’s Objective Response Rate in Females with Colorectal Cancer thumbail
View all blog posts

LATEST TWEETS

Follow us on Twitter